Do pharmaceuticals present a risk to the environment, and what needs to be done to answer the question?
Sumpter, John P.
Brown, A. Ross
Environmental Toxicology and Chemistry
Licenced under a Creative Commons Attribution 4.0 International License http://creativecommons.org/choose/
Reason for embargo
Although human pharmaceuticals are currently considered as emerging contaminants, many have been present in the aquatic environment for decades. Two facts make pharmaceuticals in the environment an issue of concern. One is that there are a few thousand different pharmaceuticals, and the other is that all of them are biologically active, at least in humans. These 2 facts lead us, in turn, to the 2 key unresolved issues related to pharmaceuticals in the environment. First, how should we conduct a prioritization exercise to identify those pharmaceuticals likely to be of the greatest environmental risk? Second, are typical environmental concentrations of those pharmaceuticals anywhere close to the concentrations that produce adverse effects in ecotoxicity tests? This Perspectives column addresses these 2 key issues.
AstraZeneca Global SHE Research Programme
This is the accepted version of the following article: Sumpter, J. P. (2014), The challenge: Do pharmaceuticals present a risk to the environment, and what needs to be done to answer the question?. Environmental Toxicology and Chemistry, 33: 1915. doi: 10.1002/etc.2666, which has been published in final form at http://dx.doi.org/10.1002/etc.2666
Commentary/ discussion paper concerning whether or not pharmaceuticals present a risk to the environment, and what needs to be done to answer the question.
Vol. 33 (9), pp. 1915 – 918